CS MEDICA A/S: CS MEDICA received the first order, valued DKK 2.6 million, for the Israeli market
CS MEDICA (”CS MEDICA” or the ”Company”) announces today that the Company has just received the first order from their partner Forbe HealthCare Ltd in Israel. This first order amounts to DKK 2.6 million, out of the agreed order minimum, of DKK 37,1 million, covering the next 3.5 years. CS MEDICA'S CBD product line will be the first CBD products launched at the Israeli market.CS MEDICA has just received the first order for the Israeli market from their partner Forbe HealthCare Ltd. The order includes all CS MEDICA’s medical CBD products, CANNASEN® CBD Arthritis-, Psoriasis-, Protective